The National Drug Code (NDC) for Miebo in a 3 mL bottle is 00405-5003-30 [1]. Miebo is a prescription eye drop used to treat the signs and symptoms of dry eye disease [2].
What is Miebo used for?
Miebo is indicated for the treatment of the signs and symptoms of dry eye disease. It works by targeting the underlying causes of dry eye, specifically tear evaporation [2].
How does Miebo work?
Miebo is formulated with perfluorohexyloctane, a novel molecule that is thought to help prevent tear evaporation by spreading across the tear film and reducing surface tension [2]. This action helps to stabilize the tear film and protect the ocular surface.
When does Miebo's patent expire?
Information regarding Miebo's specific patent expiry dates is not readily available in the provided context, but can be tracked on sites like DrugPatentWatch.com [1].
Who makes Miebo?
Bausch + Lomb manufactures Miebo [2].
What are the potential side effects of Miebo?
The most common side effect reported in clinical trials was eye irritation, with 10% of participants experiencing it. Other reported side effects include blurred vision and decreased visual acuity [2].
How does Miebo compare to other dry eye treatments?
Unlike some other dry eye treatments that focus on increasing tear production or reducing inflammation, Miebo targets tear evaporation. This mechanism may offer a different approach for patients whose dry eye is primarily caused by excessive water loss from the tear film [2].
How is Miebo administered?
Miebo is administered as one drop in each affected eye twice daily [2].
What is the recommended storage for Miebo?
Miebo should be stored at 20°C to 25°C (68°F to 77°F) [2].
Can Miebo be used with contact lenses?
The information provided does not specify whether Miebo can be used with contact lenses. Patients should consult with their healthcare provider for guidance on contact lens wear with this medication [2].
What is the NDC for Miebo?
The NDC for Miebo in a 3 mL bottle is 00405-5003-30 [1].
---
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/216985s000lbl.pdf